CANCER IMMUNOTHERAPY BY DELIVERING CLASS II MHC ANTIGENS USING A VLP-REPLICON
Technology
E-050-2014
Patent ID
E-050-2014-0-US-18
Country
US
Application Type
DIV
Patent Status
Issued
Patent Number
11718861
Publication Number
US-2021-0163988-A1
Application Number
17/120,497
IC
NCI
Date Filed
Date Issued